// App-Quantinova.ai

SAT0505 : PLUTO TRIAL OF INTRAVENOUS BELIMUMAB IN PAEDIATRIC PATIENTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE): PATIENT RESPONSES OVER TIME

Researchers

Presenter

  • N. Ruperto

Principal Investigators

  • L. Mccann

  • S. Takei

  • C. Pilkington

  • D. Bass

  • B. Ji

  • A. Hammer

  • M. Okily

  • G. Eriksson

  • H. Quasny

  • H. Brunner

Medical Centers

  • Istituto Giannina Gaslini, Genoa, Italy

  • Microbiology, Alder Hey Childrens Hospital, Liverpool, United Kingdom

  • Great Ormond Street Hospital, London, United Kingdom

  • GlaxoSmithKline plc, Collegeville, United States of America

  • GlaxoSmithKline, Uxbridge, United Kingdom

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • Perinatal Institute, Cincinnati Children’s Hospital, Cincinnati, United States of America

Locations

  • Italy

  • United Kingdom

  • Japan

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • Somatostatin

Drug/Treatment

  • Belimumab

  • Estrogens

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • II

Study Id's

  • NCT01649765

Sponsors

  • Eisai Co., Ltd.

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved